We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
BioVaxys Technology Corp. is pleased to announce a non-brokered private placement consisting of up to 9,090,909 units at a price of $0.22 per Unit for total gross proceeds of up to approximately $2,000,000.
The securities to be issued under the Offering will be offered pursuant to applicable exemptions from the prospectus requirements under applicable securities laws. The Common Shares, the Warrants, the Broker Warrants and any Common Shares issuable upon e